How to Reverse Aging: What Science Actually Shows (2026)

What Does "Reverse Aging" Actually Mean?

Aging is not a single process. It is the simultaneous deterioration of at least 12 interconnected biological systems, identified in the scientific literature as the hallmarks of aging: genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, altered intercellular communication, disabled macroautophagy, chronic inflammation, and dysbiosis.

"Reversing aging" could mean addressing any or all of these. In practice, the field has converged on one primary metric: epigenetic clocks, algorithms that estimate biological age from DNA methylation patterns. The most validated clocks include Steve Horvath's original clock (2013), GrimAge (which predicts mortality risk), PhenoAge (which incorporates clinical biomarkers), and DunedinPACE (which measures the current rate of aging).

When researchers say an intervention "reversed aging," they typically mean it reduced biological age on one of these clocks. That is a meaningful finding, because epigenetic age acceleration predicts all-cause mortality, cardiovascular disease, cancer, and cognitive decline at a population level. But epigenetic clock reductions are a surrogate marker, not proof of lifespan extension. No intervention has been proven to extend human lifespan in a controlled trial.

With that framework in mind, here is what actually works, what is promising, and what is speculation, ranked by the strength of the evidence available in 2026.

Can Exercise Reverse Aging?

If there is a single intervention with the strongest evidence for reversing biological aging in humans, it is structured exercise. Not general physical activity like walking the dog or taking the stairs, but planned, repetitive, progressive training programs that increase cardiorespiratory fitness and muscular strength.

A 2025 perspective review published in Aging by Kawamura and colleagues at Tohoku University synthesized evidence from both human and animal studies. The core finding: structured exercise training can induce "epigenomic rejuvenation" in blood and skeletal muscle. One study cited in the review found that sedentary middle-aged women reduced their epigenetic age by two years after just eight weeks of combined aerobic and strength training.

A 2026 pilot study published in GeroScience (De Meyer et al.) tested six months of cycling-based endurance training in 42 adults aged 35-65. Participants improved VO2 max by 20% (p < 0.001). GrimAge decreased by 7.44 months relative to the expected trajectory (p = 0.012). The GrimAge reduction correlated with VO2 max improvement (R² = 0.27, p = 0.002) but not with body composition changes alone, suggesting that cardiorespiratory fitness itself is the driver, not just weight loss.

The dose that appears to matter: the Kawamura review found that VO2 peak and VO2 at ventilatory threshold were more strongly associated with lower epigenetic age acceleration than grip strength or leg extension power. Higher cardiorespiratory fitness predicted younger biological age. Olympic champions showed lower epigenetic age acceleration than non-champions who trained at similar intensities.

What this means practically: if you do nothing else on this list, exercise. Aim for 150+ minutes per week of moderate cardiovascular training (or 75 minutes vigorous), combined with resistance training 2-3 times per week. Specific protocols that showed epigenetic age reduction in published studies include cycling (the De Meyer GeroScience trial), combined aerobic + resistance circuits (the study showing 2-year reduction in sedentary women), and walking programs in older adults. VO2 max improvement appears to be the strongest predictor of epigenetic age reduction, so prioritize progressive cardiovascular challenge over comfortable steady-state. If you currently do not exercise, starting with 30 minutes of brisk walking three times per week and adding resistance training produces meaningful fitness gains within 8-12 weeks. This is not new advice. It is, however, now backed by epigenetic clock data showing measurable biological age reduction in controlled studies.

Can Diet and Lifestyle Reverse Biological Age?

A 2021 pilot RCT by Kara Fitzgerald and colleagues, published in Aging, tested an eight-week diet and lifestyle intervention in 43 healthy adult males aged 50-72. The protocol included a specific diet (high in folate, betaine, and polyphenols, moderate in animal protein), supplementation (probiotics and phytonutrient powder), exercise guidance (30 minutes daily, 5 days per week), stress management (twice-daily breathing exercises), and sleep optimization (minimum 7 hours).

The treatment group showed a 3.23-year decrease in Horvath clock biological age compared to controls (p = 0.018). This is one of the largest epigenetic age reductions documented in a controlled human trial from a non-pharmaceutical intervention.

The limitation: this was a small pilot study (n = 43) with only male participants. The specific contributions of each protocol component (diet, exercise, sleep, stress management, supplements) cannot be separated. The result has not yet been replicated in a larger, more diverse population. But as a proof of concept that lifestyle changes can measurably reduce biological age in weeks rather than years, it is significant.

What Did the TRIIM Trial Show About Age Reversal?

The TRIIM (Thymus Regeneration, Immunorestoration, and Insulin Mitigation) trial, led by Greg Fahy and published in Aging Cell in 2019, remains the most striking human aging reversal result to date. Ten healthy men aged 51-65 (across two cohorts, nine completing analysis) received a combination of recombinant human growth hormone (rhGH), DHEA, and metformin over 12 months.

The results: participants showed regeneration of thymic tissue (the thymus produces new T cells and normally atrophies after puberty), improved immune profiles, and a mean 2.5-year reversal of epigenetic age on the GrimAge clock. The epigenetic age reversal persisted six months after treatment discontinuation.

TRIIM-X, the follow-up trial with a larger cohort including women, began enrollment and has reported preliminary data showing 20% improvements in physical fitness measures and reduction in body fat. The predicted completion date was December 2025, with full results expected in 2026.

The caveat: TRIIM was a tiny, uncontrolled study (n = 9, no placebo group). Growth hormone carries significant risks including insulin resistance, fluid retention, and theoretical cancer risk from elevated IGF-1. The combination protocol (GH + DHEA + metformin) requires physician supervision and is not available as a consumer product. This is not a self-administered anti-aging strategy. But as evidence that biological age reversal is achievable in living humans, it remains a landmark.

Does NAD+ Restoration Reverse Aging?

NAD+ (nicotinamide adenine dinucleotide) declines roughly 50% between ages 30 and 70. This decline impairs sirtuin activity (the enzymes that regulate DNA repair and epigenetic stability), reduces mitochondrial energy production, and weakens the cell's ability to respond to stress. NAD+ decline is now recognized as one of the 12 hallmarks of aging.

NMN (nicotinamide mononucleotide) is the direct biochemical precursor to NAD+. A January 2026 trial published in Nature Metabolism (Christen et al., 65 healthy adults) confirmed that both NMN and NR approximately double whole-blood NAD+ concentrations in 14 days at 1,000 mg/day. A 2026 meta-analysis pooling 12 RCTs and 513 participants confirmed reliable NAD+ elevation across studies.

The question that matters for reverse aging: does restoring NAD+ reduce biological age? The evidence is preliminary but directional. NAD+ feeds into sirtuin-mediated chromatin remodeling and DNA methylation maintenance, the exact processes that epigenetic clocks measure. Individual user reports of biological age reduction after NMN supplementation exist, but no controlled trial has yet used epigenetic age as a primary endpoint for NMN. Several such trials are underway with results expected in 2026-2027.

What is established: NMN reliably raises NAD+ (the biochemical signal is confirmed). A 12-week trial (Morifuji et al., 2024) showed improved walking speed and sleep quality in older adults at 250 mg/day. The safety profile is clean across published trials at doses up to 1,250 mg/day. For most people, NMN at 250-500 mg/day is a reasonable protocol targeting NAD+ restoration as one component of a multi-pathway aging strategy. See our best NMN supplements guide for product selection, or our NAD+ supplement guide for how NMN compares to NR and niacin.

How Close Is Epigenetic Reprogramming to Reversing Aging?

Partial epigenetic reprogramming, the transient expression of Yamanaka factors (Oct4, Sox2, Klf4, and sometimes c-Myc) to reset age-associated epigenetic marks while preserving cell identity, is the intervention with the highest theoretical potential for age reversal.

In animal models, cyclic partial reprogramming has extended lifespan, improved muscle regeneration, enhanced pancreatic function, and restored youthful epigenetic profiles in mice. A 2024 study by Rejuvenate Bio (Macip et al.) showed that systemically delivered AAV-OSK gene therapy in 124-week-old mice extended median remaining lifespan by 109% over controls while improving frailty scores.

In 2026, Life Biosciences received FDA IND clearance for ER-100, the first human trial of a reprogramming therapy, targeting optic neuropathies. The therapy uses three Yamanaka factors (OSK, excluding the cancer-associated c-Myc) delivered locally to the eye through a doxycycline-inducible system. If the eye trial succeeds, it opens a regulatory pathway for reprogramming therapies in other tissues. For full details, see our longevity research news review.

Altos Labs ($3 billion, backed by Jeff Bezos), Retro Biosciences (backed by Sam Altman), and NewLimit (backed by Brian Armstrong) are all developing related approaches but none has reached human trials.

For consumers in 2026: partial reprogramming is not accessible outside of clinical trials. It represents a future direction, not a current option. The closest interventions that influence epigenetic markers today are exercise, caloric restriction, and NAD+ restoration through NMN supplementation.

Can Senolytics Reverse Aging by Clearing Zombie Cells?

Senescent cells accumulate with age, secreting inflammatory factors (the SASP, senescence-associated secretory phenotype) that damage neighboring healthy cells. Clearing these "zombie cells" with senolytic drugs has extended lifespan and healthspan in mice. The question is whether this translates to humans.

The answer so far: partially. The SToMP-AD and STAMINA trials tested dasatinib plus quercetin (D+Q) in older adults with Alzheimer's disease and mild cognitive impairment. Results showed brain penetrance of dasatinib, reduced inflammatory markers, and correlation between TNF-α reduction and cognitive improvement (MoCA scores). A Phase 2 bone health trial at Mayo Clinic showed only subtle effects. Unity Biotechnology's senolytic candidate failed two Phase 2 trials.

For consumers: quercetin is available OTC, but quercetin alone is not a senolytic. The D+Q combination requires dasatinib, which is a prescription chemotherapy drug. Fisetin (a quercetin-related flavonoid with senolytic properties in cell studies) is being investigated in human trials. Exercise, particularly high-intensity interval training, has been shown to reduce markers of cellular senescence in human muscle tissue, making it the most accessible senolytic strategy available. For the complete analysis, see our peptides and anti-aging comparison.

Do Anti-Aging Drugs Like Metformin and Rapamycin Reverse Aging?

Three prescription drugs attract the most attention in the reverse-aging conversation, each targeting different aging mechanisms.

Metformin activates AMPK and inhibits mTOR, mimicking caloric restriction. The TAME trial (Targeting Aging with Metformin) is testing whether it delays age-related diseases in non-diabetic adults. As of 2026, no efficacy results have been published. A 21-year DPP follow-up published in JAMA in 2026 found that lifestyle intervention reduced multimorbidity risk while metformin did not. The MASTERS trial showed metformin blunts muscle gains from resistance training. For metabolically healthy people who exercise, the case for metformin is currently weak.

Rapamycin inhibits mTOR and is the most reliable lifespan extender across species. The PEARL trial published 48-week results in 2025 showing acceptable safety and improved lean tissue mass and reduced pain in women taking 10 mg/week. The Dog Aging Project is testing rapamycin in companion dogs. Rapamycin requires a prescription and has real side effects (mouth sores, impaired wound healing, potential immune suppression).

GLP-1 agonists (semaglutide, tirzepatide) were developed for diabetes and obesity but show cardiovascular and kidney benefits that may extend beyond weight loss. Whether they slow biological aging independent of metabolic improvement is under investigation.

All three require medical supervision. For OTC alternatives targeting overlapping pathways, berberine activates AMPK (like metformin, without prescription), and NMN supports metabolic function through NAD+ restoration.

What Is David Sinclair's Reverse Aging Thesis?

Harvard geneticist David Sinclair, co-director of the Paul F. Glenn Center for the Biology of Human Aging, has been the most prominent public advocate for the idea that aging is reversible. His Information Theory of Aging posits that aging is driven primarily by the loss of epigenetic information, not by irreversible DNA damage, and that this loss can be corrected.

Sinclair's lab demonstrated in 2020 that expression of Yamanaka factors (OSK) could restore vision in old mice by resetting retinal ganglion cell epigenetics to a youthful state. This work was a key foundation for Life Biosciences' ER-100 human trial. His personal supplement protocol (NMN 1g/day + resveratrol 1g/day + metformin 800mg/day + vitamin D3 + vitamin K2) has been widely discussed but is explicitly a personal choice, not a clinical recommendation.

The honest assessment: Sinclair's research contributions are real and significant. The OSK retinal regeneration work is peer-reviewed and published in Nature. But his public claims about aging reversal sometimes outpace the clinical evidence. His personal supplement protocol has not been tested in a controlled trial. The gap between "aging is theoretically reversible" (which is increasingly supported by science) and "you can reverse your aging today with these supplements" (which is not proven) is the space where hype lives. The science is moving in Sinclair's direction, but it hasn't arrived at his destination yet.

How Do You Measure If You Are Reversing Aging?

If you implement reverse-aging interventions, how do you know they are working? The field offers several measurement tools, each with strengths and limitations.

Epigenetic clocks (TruDiagnostic, Elysium, GlycanAge): measure biological age from DNA methylation patterns. GrimAge and DunedinPACE are the most validated. Best used as serial measurements over time (every 6-12 months) rather than single snapshots. Cost: $200-500 per test.

VO2 max: the gold standard for cardiorespiratory fitness, which strongly correlates with biological age and all-cause mortality. A VO2 max in the top quartile for your age is associated with sharply lower death risk. Measurable at clinical exercise labs or estimated through field tests. This is the single most actionable biomarker for reverse aging.

Blood biomarkers: fasting glucose, fasting insulin, HbA1c, hsCRP (inflammation), homocysteine, vitamin D, lipid panel. These track metabolic health, which deteriorates with aging. Improvements indicate you are addressing metabolic hallmarks of aging.

Body composition: lean muscle mass and visceral fat percentage, measured by DEXA scan. Sarcopenia (muscle loss) and visceral fat accumulation are hallmarks of aging. Maintaining or increasing lean mass while reducing visceral fat is a measurable reverse-aging outcome.

Grip strength: a validated predictor of all-cause mortality in older adults. Simple, cheap, and reliable. If your grip strength is declining, your aging trajectory is accelerating. If it is improving, you are pushing back.

What Can You Actually Do to Reverse Aging in 2026?

Based on the evidence reviewed above, here is what you can actually implement today, organized by evidence strength and accessibility.

Layer 1: Lifestyle (strongest evidence, lowest cost, no prescription). Exercise 150+ minutes/week cardiovascular + resistance training 2-3x/week. This is the only intervention with controlled human data showing measurable epigenetic age reversal in multiple studies. Sleep 7-8 hours, consistent timing. Mediterranean-pattern diet rich in folate, polyphenols, and fiber. Stress management through any effective modality.

Layer 2: Evidence-based supplements (promising data, OTC, established safety). NMN 250-500 mg/day for NAD+ restoration (proven to double NAD+ in 14 days, clean safety profile). For product selection, see our best NMN supplements guide. For how NMN compares to NR and niacin, see our NAD+ supplement guide. Vitamin D3 2,000-5,000 IU/day (deficiency correlates with accelerated biological aging). Omega-3 2g EPA+DHA/day (anti-inflammatory, cardiovascular mortality reduction). Creatine 3-5g/day (muscle and cognitive preservation in older adults). Taurine 1-3g/day (strong preclinical data from a Science paper, long safety record).

Layer 3: Physician-supervised (real potential, higher risk, requires medical guidance). Rapamycin (low-dose weekly, PEARL trial data shows acceptable safety). Metformin (awaiting TAME results, exercise-blunting is a concern). GLP-1 agonists (for metabolic conditions, with emerging aging data). Anti-aging peptides (thin human evidence, evolving regulatory status).

Layer 4: Experimental (not yet accessible, highest theoretical ceiling). Partial epigenetic reprogramming (first human trial in 2026). Senolytic drugs (Phase 1 signals only). Gene therapies targeting aging pathways.

The most common mistake in the reverse-aging space is jumping to Layers 3 and 4 while Layer 1 is inconsistent. The controlled data showing exercise reduces biological age by months to years is stronger than any pharmaceutical result published to date. Get Layer 1 right first.

Frequently Asked Questions

Is it really possible to reverse aging?

Partially. Multiple interventions have reduced biological age on validated epigenetic clocks in controlled human studies. Exercise, diet-and-lifestyle protocols, and the TRIIM trial (GH + DHEA + metformin) have all demonstrated measurable epigenetic age reversal. Full reversal of aging (returning an 80-year-old to the biology of a 30-year-old) is not currently achievable and may never be. What is achievable is measurable biological age reduction on validated clocks, improved functional markers (VO2 max, grip strength, walking speed), and restoration of molecular processes (NAD+ levels, immune cell diversity, DNA methylation patterns) that deteriorate with age. But slowing biological aging and reversing specific aging markers is demonstrably possible with current science.

What is the best supplement to reverse aging?

No supplement has been proven to reverse aging in a controlled human trial using epigenetic age as an endpoint. The supplement with the most relevant human trial data is NMN, which doubles NAD+ (a coenzyme that declines with aging and drives multiple hallmarks of aging) in 14 days. Whether NAD+ restoration translates to measurable epigenetic age reversal is being tested in ongoing trials. For product guidance, see our best NMN supplements review.

Can exercise reverse aging?

Yes, based on epigenetic clock data. Structured exercise programs (not just casual activity) have reduced biological age by months to years in controlled studies. A 2026 GeroScience study showed 6 months of cycling training reduced GrimAge by 7.44 months. An earlier study found 8 weeks of combined aerobic and strength training reduced epigenetic age by 2 years in sedentary women. VO2 max is the fitness metric most strongly associated with biological age.

What did David Sinclair do to reverse aging?

David Sinclair's lab demonstrated that three Yamanaka factors (OSK) restored vision in old mice by resetting retinal epigenetics. His personal protocol includes NMN 1g/day, resveratrol 1g/day, metformin 800mg/day, vitamin D3, and vitamin K2. This is a personal routine, not a tested clinical protocol. The mouse vision research is peer-reviewed (Nature, 2020); the personal supplement stack has not been tested in a controlled trial.

How long does it take to reverse aging?

Epigenetic age reductions have been measured in as little as 8 weeks (Fitzgerald diet-and-lifestyle trial: -3.23 years on Horvath clock). Exercise-induced GrimAge reductions were measured at 6 months. NAD+ elevation from NMN occurs within 14 days, though downstream functional effects may take longer. The timeline depends on the intervention, the baseline health of the individual, and which aging metric you are tracking.

When will reverse aging be possible for everyone?

Partial reverse aging is possible right now through exercise, diet, and supplementation. Pharmaceutical reverse-aging protocols (like TRIIM) are available through specialized physicians today. The question is when scalable, high-impact therapies (like epigenetic reprogramming) will become clinically available. The most optimistic estimates place partial reprogramming therapies 5-10 years from widespread availability, with the first human trial (ER-100 for eye conditions) running in 2026. However, partial reverse aging through exercise and lifestyle is possible right now, documented in multiple controlled studies. The question is not whether aging can be slowed or partially reversed (it can, based on published data), but when the high-impact pharmaceutical and genetic tools will become widely accessible to complement what lifestyle and supplements already offer.

Sources

1. Kawamura T, Higuchi M, Radak Z, Taki Y. "Exercise as a geroprotector: focusing on epigenetic aging." Aging (Albany NY). 2025;17. DOI
2. De Meyer T, Stegen S, Rietzschel ER, et al. "Epigenetic age deceleration reflects exercise-induced cardiorespiratory fitness improvements." GeroScience. 2026. DOI
3. Fitzgerald KN, Hodges R, Hanes D, et al. "Potential reversal of epigenetic age using a diet and lifestyle intervention: a pilot RCT." Aging. 2021;13(7):9419-9432 (2024 correction: within-group figure revised; between-group -3.23y unchanged). PubMed
4. Fahy GM, et al. "Reversal of epigenetic aging and immunosenescent trends in humans." Aging Cell. 2019;18(6):e13028. PubMed
5. Christen S, Cuenoud B, et al. "The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans." Nature Metabolism. 2026;8(1):62-73. PubMed
6. Life Biosciences. ER-100 IND clearance for epigenetic reprogramming. 2026. Report
7. Lu Y, et al. "Reprogramming to recover youthful epigenetic information and restore vision." Nature. 2020;588:124-129. PubMed
8. Macip CC, Hasan R, Lu YR, Davidsohn N, et al. "Gene therapy-mediated partial reprogramming extends lifespan and reverses age-related changes in aged mice." Cellular Reprogramming. 2024;26(1):24-32 (124-week mice, +109% median remaining lifespan). PubMed
9. Gonzales MM, Orr ME, et al. "Senolytic therapy in mild Alzheimer's disease: SToMP-AD Phase 1." Nature Medicine. 2023;29(10):2481-2488. PubMed
10. Millar CL, Iloputaife I, Lipsitz LA, et al. "A pilot study of senolytics to improve cognition and mobility (STAMINA)." eBioMedicine. 2025 Mar;113:105612. PubMed
11. Moel M, et al. "Influence of rapamycin on safety and healthspan metrics after one year: PEARL trial." Aging. 2025;17(4):908-936. PubMed
12. Salive ME, et al. "Lifestyle and metformin interventions and risk of multimorbidity: DPP 21-year follow-up." JAMA. 2026;336(7):577-586. PubMed
13. Yi L, Maier AB, Tao R, et al. "NMN supplementation in healthy middle-aged adults." GeroScience. 2023;45(1):29-43. PubMed
14. Singh P, Yadav VK, et al. "Taurine deficiency as a driver of aging." Science. 2023;380(6649):eabn9257. PubMed